These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 34818667)

  • 1. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.
    Liu Y; Liu J; Plante KS; Plante JA; Xie X; Zhang X; Ku Z; An Z; Scharton D; Schindewolf C; Widen SG; Menachery VD; Shi PY; Weaver SC
    Nature; 2022 Feb; 602(7896):294-299. PubMed ID: 34818667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N501Y spike substitution enhances SARS-CoV-2 transmission.
    Liu Y; Liu J; Plante KS; Plante JA; Xie X; Zhang X; Ku Z; An Z; Scharton D; Schindewolf C; Menachery VD; Shi PY; Weaver SC
    bioRxiv; 2021 Mar; ():. PubMed ID: 33758836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 spike D614G change enhances replication and transmission.
    Zhou B; Thao TTN; Hoffmann D; Taddeo A; Ebert N; Labroussaa F; Pohlmann A; King J; Steiner S; Kelly JN; Portmann J; Halwe NJ; Ulrich L; Trüeb BS; Fan X; Hoffmann B; Wang L; Thomann L; Lin X; Stalder H; Pozzi B; de Brot S; Jiang N; Cui D; Hossain J; Wilson MM; Keller MW; Stark TJ; Barnes JR; Dijkman R; Jores J; Benarafa C; Wentworth DE; Thiel V; Beer M
    Nature; 2021 Apr; 592(7852):122-127. PubMed ID: 33636719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.
    Villoutreix BO; Calvez V; Marcelin AG; Khatib AM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 spike evolutionary behaviors; simulation of N501Y mutation outcomes in terms of immunogenicity and structural characteristic.
    Rostami N; Choupani E; Hernandez Y; Arab SS; Jazayeri SM; Gomari MM
    J Cell Biochem; 2022 Feb; 123(2):417-430. PubMed ID: 34783057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta.
    Ulrich L; Halwe NJ; Taddeo A; Ebert N; Schön J; Devisme C; Trüeb BS; Hoffmann B; Wider M; Fan X; Bekliz M; Essaidi-Laziosi M; Schmidt ML; Niemeyer D; Corman VM; Kraft A; Godel A; Laloli L; Kelly JN; Calderon BM; Breithaupt A; Wylezich C; Berenguer Veiga I; Gultom M; Osman S; Zhou B; Adea K; Meyer B; Eberhardt CS; Thomann L; Gsell M; Labroussaa F; Jores J; Summerfield A; Drosten C; Eckerle IA; Wentworth DE; Dijkman R; Hoffmann D; Thiel V; Beer M; Benarafa C
    Nature; 2022 Feb; 602(7896):307-313. PubMed ID: 34937050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the SARS-CoV-2 spike protein in the human host.
    Wrobel AG; Benton DJ; Roustan C; Borg A; Hussain S; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Nat Commun; 2022 Mar; 13(1):1178. PubMed ID: 35246509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants.
    Laffeber C; de Koning K; Kanaar R; Lebbink JHG
    J Mol Biol; 2021 Jul; 433(15):167058. PubMed ID: 34023401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity.
    Kumar V; Singh J; Hasnain SE; Sundar D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.
    Luan B; Wang H; Huynh T
    FEBS Lett; 2021 May; 595(10):1454-1461. PubMed ID: 33728680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.
    Abdulnoor M; Eshaghi A; Perusini SJ; Broukhanski G; Corbeil A; Cronin K; Fittipaldi N; Forbes JD; Guthrie JL; Kus JV; Li Y; Majury A; Mallo GV; Mazzulli T; Melano RG; Olsha R; Sullivan A; Tran V; Patel SN; Allen VG; Gubbay JB
    Microbiol Spectr; 2022 Feb; 10(1):e0068121. PubMed ID: 35170989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
    Zhu X; Mannar D; Srivastava SS; Berezuk AM; Demers JP; Saville JW; Leopold K; Li W; Dimitrov DS; Tuttle KS; Zhou S; Chittori S; Subramaniam S
    PLoS Biol; 2021 Apr; 19(4):e3001237. PubMed ID: 33914735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
    Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M
    EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 beta variant substitutions alter spike glycoprotein receptor binding domain structure and stability.
    Moss DL; Rappaport J
    J Biol Chem; 2021 Dec; 297(6):101371. PubMed ID: 34756892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.
    Hou YJ; Chiba S; Halfmann P; Ehre C; Kuroda M; Dinnon KH; Leist SR; Schäfer A; Nakajima N; Takahashi K; Lee RE; Mascenik TM; Graham R; Edwards CE; Tse LV; Okuda K; Markmann AJ; Bartelt L; de Silva A; Margolis DM; Boucher RC; Randell SH; Suzuki T; Gralinski LE; Kawaoka Y; Baric RS
    Science; 2020 Dec; 370(6523):1464-1468. PubMed ID: 33184236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.
    Salleh MZ; Derrick JP; Deris ZZ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational decomposition reveals reshaping of the SARS-CoV-2-ACE2 interface among viral variants expressing the N501Y mutation.
    Socher E; Conrad M; Heger L; Paulsen F; Sticht H; Zunke F; Arnold P
    J Cell Biochem; 2021 Dec; 122(12):1863-1872. PubMed ID: 34516024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.